US FDA Approval Versus Patient Access: A Real-World Anecdote
Executive Summary
During meeting on real-world evidence, FDA’s Bob Temple describes real-world problem of patient access: his struggles to convince his insurer to cover Lilly/BI's diabetes drug Jardiance – which he helped review.